HK1053254A1 - Device and method for treating urinary incontinence in females - Google Patents

Device and method for treating urinary incontinence in females

Info

Publication number
HK1053254A1
HK1053254A1 HK03103992.9A HK03103992A HK1053254A1 HK 1053254 A1 HK1053254 A1 HK 1053254A1 HK 03103992 A HK03103992 A HK 03103992A HK 1053254 A1 HK1053254 A1 HK 1053254A1
Authority
HK
Hong Kong
Prior art keywords
ring
oxybutynin
females
urinary incontinence
treating urinary
Prior art date
Application number
HK03103992.9A
Other languages
English (en)
Inventor
Anu Mahashabde
Martha Francine Kay
Donald F Koelmel
Original Assignee
Enhance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enhance Pharmaceuticals Inc filed Critical Enhance Pharmaceuticals Inc
Publication of HK1053254A1 publication Critical patent/HK1053254A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
HK03103992.9A 2000-03-21 2003-06-05 Device and method for treating urinary incontinence in females HK1053254A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/531,856 US6436428B1 (en) 2000-03-21 2000-03-21 Device and method for treating urinary incontinence in females
PCT/US2001/008978 WO2001070154A1 (en) 2000-03-21 2001-03-21 Device and method for treating urinary incontinence in females

Publications (1)

Publication Number Publication Date
HK1053254A1 true HK1053254A1 (en) 2003-10-17

Family

ID=24119337

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03103992.9A HK1053254A1 (en) 2000-03-21 2003-06-05 Device and method for treating urinary incontinence in females

Country Status (13)

Country Link
US (2) US6436428B1 (ja)
EP (2) EP1278494B1 (ja)
JP (3) JP5265836B2 (ja)
AT (1) ATE437630T1 (ja)
AU (2) AU4590101A (ja)
BR (1) BR0109691A (ja)
CA (1) CA2403475C (ja)
DE (1) DE60139389D1 (ja)
ES (1) ES2332262T3 (ja)
HK (1) HK1053254A1 (ja)
IL (2) IL151858A0 (ja)
MX (1) MXPA02009358A (ja)
WO (1) WO2001070154A1 (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
JP2005503389A (ja) * 2001-08-31 2005-02-03 シエーリング オサケユイチア 薬物送達システム
MXPA04006017A (es) * 2001-12-20 2005-06-08 Femmepharma Inc Suministro de farmacos por via vaginal.
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
FR2843303B1 (fr) * 2002-08-07 2006-01-21 R & D Pharma Nouvelles compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
US6770025B2 (en) 2002-09-18 2004-08-03 Kimberly-Clark Worldwide, Inc. Molar shaped vaginal incontinence insert
US6676594B1 (en) 2002-09-18 2004-01-13 Kimberly-Clark Worldwide, Inc. C-shaped vaginal incontinence insert
US7263999B2 (en) * 2002-10-30 2007-09-04 Kabushiki Kaisha Kitazato Supply Ring for preventing prolapse of uterus and urinary bladder and ring for preventing prolapse of uterus and rectum
US6808485B2 (en) 2002-12-23 2004-10-26 Kimberly-Clark Worldwide, Inc. Compressible resilient incontinence insert
JP2006515026A (ja) * 2003-01-02 2006-05-18 フェムファーマ ホールディング カンパニー， インコーポレイテッド 乳房の疾患および障害の処置のための薬学的調製物
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US8007568B2 (en) * 2006-04-12 2011-08-30 Millipore Corporation Filter with memory, communication and pressure sensor
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US7717892B2 (en) 2006-07-10 2010-05-18 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
BRPI0714288B1 (pt) 2006-07-10 2018-06-26 Mcneil-Ppc, Inc. Dispositivo de incontinência urinária intravaginal
CA2674078C (en) * 2006-12-26 2012-03-20 Femmepharma Holding Company, Inc. Topical administration of danazol
CN101827581A (zh) * 2007-06-26 2010-09-08 沃纳奇尔科特有限责任公司 用于递送大分子和水溶性药物的阴道内药物递送装置
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US20110028922A1 (en) * 2009-07-31 2011-02-03 Kay Dennis M Female External Incontinence Device
BR112012032951A2 (pt) * 2010-06-22 2018-02-27 Teva Womens Health Inc dispositivo intravaginal e método de fazer um dispositivo intravaginal
CA2808276A1 (en) * 2010-08-20 2012-02-23 Teva Women's Health, Inc. Intravaginal devices, methods of making, and uses thereof
JP2014506935A (ja) * 2011-03-03 2014-03-20 アラーガン インコーポレイテッド シリコーンベースの非水系眼科製剤
CN107405299A (zh) * 2015-01-30 2017-11-28 里加利私人有限公司 阴道药物递送装置
WO2019084469A1 (en) 2017-10-27 2019-05-02 Renovia Inc. DEVICES, SYSTEMS, AND METHODS FOR PELVIC FLOOR MUSCLE TRAINING

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286587A (en) 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4402695A (en) 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
MX9302812A (es) 1992-05-13 1993-11-01 Alza Corp Administracion transdermica de oxibutinina.
US5900250A (en) 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
JP3066515B2 (ja) * 1992-11-11 2000-07-17 久光製薬株式会社 尿失禁治療用経皮投与製剤
AU676430B2 (en) 1994-03-07 1997-03-06 Theratech, Inc. Drug-containing adhesive composite transdermal delivery device
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5677346A (en) 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US5532278A (en) 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5674895A (en) * 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin
US5912268A (en) 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
JP2001502302A (ja) 1996-09-19 2001-02-20 アメリカン・ホーム・プロダクツ・コーポレイション 尿失禁を治療する方法
DE19812413C1 (de) * 1998-03-20 1999-06-10 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
US6087396A (en) 1998-10-05 2000-07-11 Situs Corporation Oxybutynin formulations and method of use
AU1256399A (en) 1998-10-07 2000-04-26 Alza Corporation Controlled release dosage from comprising oxybutynin
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
MX2007000273A (es) * 2004-07-09 2007-05-21 Population Council Inc Composiciones de liberacion sostenida que contiene moduladores del receptor de progesterona.

Also Published As

Publication number Publication date
BR0109691A (pt) 2003-06-10
EP1278494B1 (en) 2009-07-29
JP5265836B2 (ja) 2013-08-14
JP5986149B2 (ja) 2016-09-06
DE60139389D1 (de) 2009-09-10
WO2001070154A1 (en) 2001-09-27
CA2403475A1 (en) 2001-09-27
JP2014210802A (ja) 2014-11-13
EP1278494A1 (en) 2003-01-29
EP2106785A1 (en) 2009-10-07
AU2001245901B2 (en) 2004-10-07
ES2332262T3 (es) 2010-02-01
AU4590101A (en) 2001-10-03
EP1278494A4 (en) 2005-11-02
EP2106785B1 (en) 2016-12-07
MXPA02009358A (es) 2003-09-25
IL151858A (en) 2009-12-24
CA2403475C (en) 2011-02-08
JP2003527404A (ja) 2003-09-16
IL151858A0 (en) 2003-04-10
WO2001070154A9 (en) 2001-12-20
ATE437630T1 (de) 2009-08-15
US20020090390A1 (en) 2002-07-11
JP5675865B2 (ja) 2015-02-25
JP2013107895A (ja) 2013-06-06
US6436428B1 (en) 2002-08-20

Similar Documents

Publication Publication Date Title
HK1053254A1 (en) Device and method for treating urinary incontinence in females
JP2003527404A5 (ja)
EP1279381A3 (fr) Dispositif intra-vaginal de prévention de l'incontinence urinaire féminine
AR031721A1 (es) Un dispositivo para la incontinencia urinaria y un metodo para hacer el mismo
GB2364916B (en) Drug delivery device
WO2002053071A8 (en) Female incontinence control device
ATE308937T1 (de) Ausdehnbare schlinge zur behandlung von harninkontinenz
CY1108296T1 (el) Σετ χειρουργικων εργαλειων για τη θεραπεια της γυναικειας ακρατειας ουρων
DE60141145D1 (ja)
CA2497907A1 (en) C-shaped vaginal incontinence insert
ZA912984B (en) Treatment of erectile dysfunction
HUT77206A (hu) Méhen belüli eszköz felhelyezésére szolgáló bevezető eszköz és ezekből álló készlet
MXPA05009816A (es) Composiciones y metodos para el tratamiento de la eyaculacion precoz.
GB0019107D0 (en) Balloon-free uninary catheter
WO2001013780A3 (en) Apparatus and method for anesthetizing the cervical region of a female
NZ509894A (en) A "T" or "Y" shaped intravaginal device suitable for delivery of pharmaceuticals such as progesterone
AU1898597A (en) Novel intrauterine device for use as contraceptive means in female dogs and methods of insertion thereof
CA2401081A1 (en) Method and device for intra-urethral incontinence
ATE307544T1 (de) Harninkontinenzvorrichtung
Chen Refinement of McIndoe's vaginal reconstruction with ORFIT “S” vaginal stent
GB2384434A (en) Method and apparatus for treating and preventing urinary tract infections
Parmer Long-term suppression of hypermenorrhea by progesterone intrauterine contraceptive devices
WO2004014360A3 (fr) Compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
TW200600089A (en) Vaginally administered anti-dysrhythmic agents for treating pelvic pain
UA32061A (uk) Спосіб хірургічного лікування вторинної глаукоми

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170321